Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations

Figure 2

Differentiation of BT474 cells as determined by Nile red staining of neutral lipids. BT474 cells were either untreated or treated with vehicle (ethanol + PBS), 50 ng/ml heregulin β1, 1 μM all-trans retinoic acid (atRA), 1 μg/ml trastuzumab, 1 μM tamoxifen, 1 μM atRA + 1 μg/ml trastuzumab (Tzmab), 1 μM atRA + 1 μM tamoxifen (Tam), 1 μg/ml trastuzumab (Tzmab) + 1 μM tamoxifen (Tam), or 1 μM atRA + 1 μg/ml trastuzumab (Tzmab) + 1 μM tamoxifen (Tam). On day 6 following treatment, the cells were collected and stained with the fluorescent dye Nile red. The fluorescence intensities of the cells were analyzed by flow cytometry and expressed relative to the intensity of the untreated cells. Results are mean of eight independent experiments ± standard error.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us